Changes to Beneficiary Coinsurance for Additional Procedures Furnished During the Same Clinical Encounter As Certain Colorectal Cancer Screening Tests
Implements the gradual reduction in coinsurance until coinsurance is completely waived for certain Colorectal Cancer screening procedures that become a diagnostic or therapeutic service. This reduction and eventual waiver of coinsurance is authorized by Section 122 of Division CC of the Consolidated Appropriations Act (CAA) of 2021
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 29, 2022
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.